The results of several studies about the effectiveness of recombinant luteinizing hormone
(rLH) supplementation in poor responder in vitro fertilization (IVF) patients were conflicting …

The objective of this meta-analysis is to assess the impact of LH supplementation in women
undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) with gonadotropin …

Introduction Luteinizing hormone (LH) is believed to play a role in follicle maturation during
the natural cycle. However, the need for co-treatment with recombinant LH (rLH) for …

Objective To present an evidence-based rationale for or against the use of supplemental
luteinizing hormone (LH) versus follicle-stimulating hormone (FSH) alone in various …

Objective To assess the role of recombinant human LH (r-hLH) supplementation in ovarian
stimulation for ART in specific subgroups of patients. Design Systematic review. Setting …

OBJECTIVE: To evaluate the efficacy of two doses of recombinant (r) LH, 75 IU
(recommended) or 37.5 IU, for follicular stimulation and outcomes in a randomized cohort of …

Although it is widely accepted that patients, who are considered poor responders to in vitro
fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during …

Luteinizing hormone (LH) is crucial for the development of follicular growth and oocyte
maturation, especially in the management of poor ovarian responders (PORs). This study …

Purpose: to compare the efficacy of recombinant LH supplementation for controlled ovarian
stimulation in recombinant FSH and GnRH-agonist protocol. Methods: Search strategies …

Objective: To look into current evidence exploring the added value of rLH supplementation
to rFSH in GnRH analogues cycles, to identify groups of women that still have no evidence …